Precision Medicine in Obesity and Diabetes
Feb 3, 2021 10:50am ‐ Feb 3, 2021 11:15am
Speaker(s):
- Paul W. Franks, PhD, Lund University
Mechanisms of Therapies for T2D and Potential Crossover to T1D
Feb 3, 2021 11:30am ‐ Feb 3, 2021 11:55am
Speaker(s):
- Rory J. McCrimmon, MD, University of Dundee
Therapies to Stop T1D…Determining Risk and Conducting Trials
Feb 3, 2021 11:55am ‐ Feb 3, 2021 12:20pm
Speaker(s):
- Carla J. Greenbaum, MD, Benaroya Research Institute at Virginia Mason
Stem Cell Mediated Treatments for Diabetes
Feb 3, 2021 12:20pm ‐ Feb 3, 2021 12:45pm
Speaker(s):
- Allan Ertmann Karlsen, PhD, Novo Nordisk
Interaction between T2D and Obesity and COVID Outcomes
Feb 3, 2021 1:30pm ‐ Feb 3, 2021 1:35pm
Speaker(s):
- Alpana P. Shukla, MD, Weill Cornell Medical College
Workshop and Panel Discussion: COVID and Diabetes
Feb 3, 2021 1:30pm ‐ Feb 3, 2021 3:00pm
Moderator(s):
- Lori Sussel, PhD, University of Colorado Anschutz Medical Campus
COVID and TID
Feb 3, 2021 1:35pm ‐ Feb 3, 2021 1:40pm
Speaker(s):
- G. Todd Alonso, MD, University of Colorado
COVID Directly Infects Beta Cells and Affects Beta Cell Function
Feb 3, 2021 1:40pm ‐ Feb 3, 2021 1:45pm
Speaker(s):
- Shuibing Chen, PhD, Weill Cornell Medical College
ACE2 is Expressed in the Islet Microvasculature and Ducts of Human Pancreas
Feb 3, 2021 1:45pm ‐ Feb 3, 2021 1:50pm
Speaker(s):
- Katie C. Coate, PhD, Vanderbilt University Medical Center